Muscarinic agonists elicit contraction through M-3, receptors in most isola
ted preparations of gastrointestinal smooth muscle, and not surprisingly, s
everal investigators have identified M-3, receptors in smooth muscle using
biochemical, immunological and molecular biological methods. However, these
studies have also shown that the M-2, receptor outnumbers the M-3, by a fa
ctor of about four in most instances. In smooth muscle, M-2 receptors media
te phosphoinositide hydrolysis and Ca2+ mobilization, whereas M, receptors
mediate an inhibition of cAMP accumulation. The inhibitory effect of the M-
2, receptor on cAMP levels suggests an indirect role for this receptor; nam
ely, an inhibition of the relaxant action of cAMP-stimulating agents. Such
a function has been rigorously demonstrated in an experimental paradigm whe
re gastrointestinal smooth muscle is first incubated with 4-DAMP mustard to
inactivate M, receptors during a Treatment Phase, and subsequently, the co
ntractile activity of muscarinic agonists is characterized during a Test Ph
ase in the presence of histamine and a relaxant agent. When present togethe
r, histamine and the relaxant agent (e.g., isoproterenol or forskolin) have
no net contractile effect because their actions oppose one another. Howeve
r, under these conditions, muscarinic agonists elicit a highly potent contr
actile response through the M-2 receptor, presumably by inhibiting the rela
xant action of isoproterenol or forskolin on histamine-induced contractions
. This contractile response is pertussis toxin-sensitive, unlike the standa
rd contractile response to muscarinic agonists, which is pertussis toxin-in
sensitive. When measured under standard conditions (i.e., in the absence of
histamine and without 4-DAMP mustard-treatment), the contractile response
to muscarinic agonists is moderately sensitive to pertussis toxin if isopro
terenol or forskolin is present. Also, pertussis toxin-treatment enhances t
he relaxant action of isoproterenol in the field-stimulated guinea pig ileu
m. These results demonstrate that endogenous acetylcholine can activate M-2
, receptors to inhibit the relaxant effects of ss-adrenoceptor activation o
n M-3, receptor-mediated contractions. An operational model for the interac
tion between M-2, and M-3, receptors shows that competitive antagonism of t
he interactive response resembles an M-3, profile under most conditions, ma
king it difficult to detect the contribution of the M-2, receptor.